Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy
Clinical trial NCT05665348 · COMPLETED
Trial details
- NCT number
- NCT05665348
- Sponsor
- Federation Francophone de Cancerologie Digestive
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-09
- Primary completion
- 2025-05-12
- Enrollment
- 229
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.